Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.

Human genomics - 16 Jan 2016

Patterson Sara E, Liu Rangjiao, Statz Cara M, Durkin Daniel, Lakshminarayana Anuradha, Mockus Susan M

Abstract excerpt

BACKGROUND: Precision medicine in oncology relies on rapid associations between patient-specific variations and targeted therapeutic efficacy. Due to the advancement of genomic analysis, a vast literature characterizing cancer-associated molecular aberrations and relative therapeutic relevance has been published. However, data are not uniformly reported or readily available, and accessing relevant information in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Decision-Making
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Knowledge Bases

Share to Molecular Targeted Therapy

Share to Neoplasm Proteins

Share to Patients

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 26772741
DOI: 10.1186/s40246-016-0061-7
PMCID: PMC4715272

Genes

CKB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.PMID 26772741Read ↗

Clinical Trials in Precision Oncology.Semantic proximity Read ↗

Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University ExperienceSemantic proximity Read ↗

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results.Semantic proximity Read ↗

Characterizing mutation-treatment effects using clinico-genomics data of 78,287 patients with 20 types of cancers.Semantic proximity Read ↗

Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer dataSemantic proximity Read ↗

Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid TumorsSemantic proximity Read ↗

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read ↗

Cancer Treatment in the Genomic EraSemantic proximity Read ↗

Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trialSemantic proximity Read ↗

Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data.Semantic proximity Read ↗

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.Semantic proximity Read ↗

Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.